JP2012533066A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012533066A5 JP2012533066A5 JP2012519652A JP2012519652A JP2012533066A5 JP 2012533066 A5 JP2012533066 A5 JP 2012533066A5 JP 2012519652 A JP2012519652 A JP 2012519652A JP 2012519652 A JP2012519652 A JP 2012519652A JP 2012533066 A5 JP2012533066 A5 JP 2012533066A5
- Authority
- JP
- Japan
- Prior art keywords
- apociii
- level
- diabetes
- subject
- subjects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 19
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 8
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 8
- 238000003745 diagnosis Methods 0.000 claims 8
- 239000008103 glucose Substances 0.000 claims 8
- 208000001280 Prediabetic State Diseases 0.000 claims 7
- 201000009104 prediabetes syndrome Diseases 0.000 claims 7
- 230000001225 therapeutic effect Effects 0.000 claims 5
- 238000012544 monitoring process Methods 0.000 claims 4
- 206010022489 Insulin Resistance Diseases 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 238000004458 analytical method Methods 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 1
- 238000005119 centrifugation Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000004043 dyeing Methods 0.000 claims 1
- 238000001502 gel electrophoresis Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22350209P | 2009-07-07 | 2009-07-07 | |
| US61/223,502 | 2009-07-07 | ||
| PCT/US2010/040998 WO2011005718A1 (en) | 2009-07-07 | 2010-07-03 | Apolipoprotein ciii in pre- and type 2 diabetes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012533066A JP2012533066A (ja) | 2012-12-20 |
| JP2012533066A5 true JP2012533066A5 (https=) | 2013-05-30 |
| JP5876826B2 JP5876826B2 (ja) | 2016-03-02 |
Family
ID=43427312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012519652A Active JP5876826B2 (ja) | 2009-07-07 | 2010-07-03 | 糖尿病前症及び２型糖尿病におけるアポリポタンパク質ｃｉｉｉ |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20110008901A1 (https=) |
| EP (1) | EP2451466B1 (https=) |
| JP (1) | JP5876826B2 (https=) |
| CN (1) | CN102481319A (https=) |
| WO (1) | WO2011005718A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8557513B2 (en) * | 2011-06-27 | 2013-10-15 | Biocrine Ab | Methods for treating and/or limiting development of diabetes |
| US9125255B2 (en) | 2012-05-03 | 2015-09-01 | Abl Ip Holding Llc | Networked architecture for system of lighting devices having sensors, for intelligent applications |
| US9901562B2 (en) | 2013-04-04 | 2018-02-27 | Lycored Ltd. | Anti-inflammatory omega-3 synergistic combinations |
| KR20200074975A (ko) | 2017-10-31 | 2020-06-25 | 스태튼 바이오테크놀로지 비.브이. | 항-ApoC3 항체 및 이의 사용 방법 |
| CN114354827A (zh) * | 2022-03-21 | 2022-04-15 | 天津云检医疗器械有限公司 | 代谢标志物及其在制备2型糖尿病的风险预测试剂盒中的应用和试剂盒 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020164818A1 (en) * | 1995-05-23 | 2002-11-07 | Gruber Karl F. | Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids |
| CA2434699A1 (en) * | 2001-01-17 | 2002-10-17 | Randall W. Nelson | An integrated high throughput system for the analysis of biomolecules |
| JP2005503537A (ja) * | 2001-01-17 | 2005-02-03 | エー． タブス，ケモンズ | 生体分子分析用ハイ・スループット統合システム |
| US6677303B2 (en) * | 2001-04-30 | 2004-01-13 | Syn X Pharma | Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons |
| ES2398110T3 (es) * | 2003-04-29 | 2013-03-13 | Biocrine Ab | ApoCIII y tratamiento y diagnóstico de la diabetes |
| US20070087448A1 (en) * | 2004-02-16 | 2007-04-19 | Nelsestuen Gary L | Biological profiles and methods of use |
| US8343534B2 (en) * | 2004-04-23 | 2013-01-01 | The Procter & Gamble Company | Tissue including a volatile rhinological composition |
| US20060110082A1 (en) * | 2004-11-24 | 2006-05-25 | Sauer-Danfoss Inc. | Compact unitized cradle swashplate bearing |
| JPWO2006073195A1 (ja) * | 2005-01-07 | 2008-06-12 | 敏一 吉川 | 糖尿病の予知・診断方法および糖尿病予知・診断用キット |
| WO2006110082A1 (en) * | 2005-04-11 | 2006-10-19 | Astrazeneca Ab | A method and a kit for diagnosing type 2 diabetes, metabolic syndrome, sub clinical atherosclerosis, myocardial infarct, stroke or clinical manifestations of diabetes. |
| WO2007025174A2 (en) * | 2005-08-26 | 2007-03-01 | Vascular And Endovascular Surgical Technologies, Inc. | Endograft |
| US20070112055A1 (en) * | 2005-09-30 | 2007-05-17 | Glenmark Pharmaceuticals Limited | Crystalline forms of almotriptan and processes for their preparation |
| JP5688829B2 (ja) * | 2005-11-11 | 2015-03-25 | 敏一 吉川 | 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット |
| AP2008004634A0 (en) * | 2006-03-23 | 2008-10-31 | Emelta De Guzman Breyer | Apolipoprotein fingerprinting technique |
| WO2007132291A2 (en) * | 2006-05-15 | 2007-11-22 | Digilab, Inc. | Biomarkers for pre-form of type 2 diabetes and methods for detecting the presence of absence of a pre-form of type 2 diabetes |
| US20080300170A1 (en) * | 2006-09-01 | 2008-12-04 | Cohava Gelber | Compositions and methods for diagnosis and treatment for type 2 diabetes |
-
2010
- 2010-07-02 US US12/829,891 patent/US20110008901A1/en not_active Abandoned
- 2010-07-03 JP JP2012519652A patent/JP5876826B2/ja active Active
- 2010-07-03 CN CN2010800370600A patent/CN102481319A/zh active Pending
- 2010-07-03 WO PCT/US2010/040998 patent/WO2011005718A1/en not_active Ceased
- 2010-07-03 EP EP10797691.2A patent/EP2451466B1/en active Active
-
2015
- 2015-01-30 US US14/610,813 patent/US20150212100A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Viswanath et al. | Recent trends in the development of diagnostic tools for diabetes mellitus using patient saliva | |
| Postuma et al. | Clinical prediction of Parkinson's disease: planning for the age of neuroprotection | |
| Choudhary et al. | Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring | |
| WO2010053587A3 (en) | Methods of monitoring conditions by sequence analysis | |
| Gerber et al. | ASVCP guidelines: quality assurance for portable blood glucose meter (glucometer) use in veterinary medicine | |
| JP2012533066A5 (https=) | ||
| EP2369346A3 (en) | Means and method for diagnosing diabetes | |
| HK1217364A1 (zh) | 唾液葡萄糖監測系統 | |
| JP2012068263A5 (https=) | ||
| WO2009132058A3 (en) | Levels of bcma protein expression on b cells and use in diagnostic methods | |
| TW200711660A (en) | Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development | |
| Bresciani et al. | Accuracy of capillary blood 3-β-hydroxybutyrate determination for the detection and treatment of canine diabetic ketoacidosis | |
| WO2013172929A1 (en) | Minimally invasive stress sensors and methods | |
| ATE537454T1 (de) | Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15 | |
| KR20170002318A (ko) | 대사체 분석을 이용한 당뇨병 조기 진단용 조성물 | |
| Zhang et al. | A strategy for the development of biomarker tests for PTSD | |
| FI13179Y1 (fi) | Laite aivovamman havaitsemiseksi kohteessa | |
| Seesaard et al. | Self-screening for diabetes by sniffing urine samples based on a hand-held electronic nose | |
| WO2009133197A3 (en) | Levels of april in serum and use in diagnostic methods | |
| JP2012533065A5 (https=) | ||
| Hadjadj et al. | Determination of HbA1c concentrations in patients with acute myocardial infarction: comparison of the DCA 2000 device with the HPLC method | |
| Wright et al. | Use of continuous glucose monitoring leads to diagnosis of hemoglobin C trait in a patient with discrepant hemoglobin A1C and self-monitored blood glucose | |
| MOHAMED et al. | Assessment of hematological biomarkers, including neutrophil-lymphocyte and platelet-lymphocyte ratios, in diabetic nephropathy for patients with type 2 diabetes | |
| Chubb et al. | The relationship between self-monitoring of blood glucose results and glycated haemoglobin in type 2 diabetes: the fremantle diabetes study | |
| Dixon et al. | The diagnostic potential of microneedles in infectious diseases |